Executive Director, Medical Diagnostics, Global Oncology Medical Affairs

Join a Legacy of Innovation 125 Years and Counting Like the look of this opportunity Make sure to apply fast, as a high volume of applications is expected Scroll down to read the complete job description. Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary As a core member of the Global Oncology Medical Affairs (GOMA) Leadership Team, this role is accountable for shaping the GOMA CDx vision and objectives as well as the holistic Companion Diagnostics Medical Affairs strategies for molecules and therapeutic areas where DS operates in oncology. This role will also oversee the execution of the global medical affairs activities related biomarkers and CDx, ensuring alignment with pipeline priorities and precision medicine goals. This role and their team will partner closely across several functions within Global Oncology Medical Affairs, Regional Medical Affairs, Precision Medicine, Clinical Development, RWE/HEOR, Discovery and Business Development as well as Oncology Business Unit Leadership Team. Responsibilities Strategic Leadership Cross-Functional Alignment: Driving the overarching medical strategy for Companion Diagnostics (CDx), fostering alignment across multiple functions and stakeholders to accelerate precision medicine efforts and maximize patient impact. Shape and define enterprise-level CDx priorities in collaboration with Medical and Cross-Functional Partners, ensuring alignment with broader portfolio and business objectives. Serve as strategic partner and advisor to Franchise Heads, GMAT, MAST leads, and regional CDx leaders, facilitating cohesive and future-forward business decisions. Influence and inform cross-functional strategies across Precision Medicine, Clinical Development, Commercial and Market Access strategies to enable integrated, patient-centric approaches. Leverage AI, emerging technologies, and data-driven insights to inform CDx strategy development, identify opportunities, and optimize cross-functional planning and execution. Medical Strategy Execution: Scientific Excellence Lead execution of global medical strategy for Companion Diagnostics (CDx) across the oncology portfolio, driving readiness, scientific leadership, and strategic alignment with internal and external partners. Drive global medical readiness for CDx launches and lifecycle management across the oncology portfolio, ensuring timely, integrated execution. Ensure strategic coherence and executional alignment of CDx medical initiatives with alliance partners and internal stakeholders, fostering a unified approach to shared objectives. Identify and work to address critical evidence and educational gaps through targeted strategies (e.g., scientific education, clinical studies) to advance biomarker and CDx understanding and application. Review and approve internal and external biomarker and CDx-related study proposals to ensure scientific integrity and strategic fit. Build and maintain high-impact, trusted partnerships with external thought leaders, diagnostic companies, and central labs to shape external understanding and adoption of CDx strategies. Collaborate with global and regional PAG leads to shape integrated medical strategies informed by precision medicine and biomarker insights. Enterprise Leadership Medical Impact: Lead cross-functional medical initiatives, contribute to enterprise-wide strategic direction, and drive operational excellence within Global Oncology Medical Affairs. Actively contribute to the strategic direction and operational excellence of Global Oncology Medical Affairs (GOMA), serving as a member of the GOMA Leadership Team and influencing long-range planning. Lead and participate in cross-functional medical initiatives, helping shape strategic decisions with insights from internal and external stakeholders. Provide strategic leadership and direction to team of biomarker and CDx experts, ensuring alignment with global medical and organizational priorities. Develop and manage the annual operating plan and budget for the GOMA biomarkers and CDx team. Define, monitor, and interpret KPIs associated with CDx strategies and tactics to assess impact, guide decision making, and optimize future organizational strategies. Qualifications Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation. MD required or PharmD required or DO required or PhD or other doctorate required. Bachelor's Degree required. 10 or more years overall related experience required. 10 or more years experience in pharmaceutical or diagnostics industry required. Multiple functions experience is preferred as well as experience in global, region and affiliate level. At least 5 years experience managing direct reports. Demonstrated track record of success leading multidisciplinary CDx development teams within a pharmaceutical company. xrczosw Travel Ability to travel up to 30%. Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law. Salary Range: $258,450.00 - $430,750.00